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Primordial germ cells (PGCs) and preimplantation
embryos undergo epigenetic reprogramming, which
includes comprehensive DNA demethylation. We
found that PRMT5, an arginine methyltransferase,
translocates from the cytoplasm to the nucleus dur-
ing this process. Here we show that conditional
loss of PRMT5 in early PGCs causes complete male
and female sterility, preceded by the upregulation
of LINE1 and IAP transposons as well as activa-
tion of a DNA damage response. Similarly, loss of
maternal-zygotic PRMT5 also leads to IAP upregula-
tion. PRMT5 is necessary for the repressive H2A/
H4R3me2s chromatin modification on LINE1 and
IAP transposons in PGCs, directly implicating this
modification in transposon silencing during DNA
hypomethylation. PRMT5 translocates back to the
cytoplasm subsequently, to participate in the pre-
viously described PIWI-interacting RNA (piRNA)
pathway that promotes transposon silencing via de
novo DNA remethylation. Thus, PRMT5 is directly
involved in genome defense during preimplantation
development and in PGCs at the time of global DNA
demethylation.
INTRODUCTION
During the mammalian life cycle, two major epigenetic reprog-
ramming events restore the developmental potential toward
the totipotent and pluripotent states: in PGCs following their
specification at embryonic days (E) 7.25–E12.5 and during
preimplantation development at E0.5–E3.5, respectively (Surani
et al., 2007). One key component of epigenome resetting is
global DNA demethylation, which renders PGCs and early em-
bryos vulnerable to the activation of transposable elements
(TEs) that are normally repressed by DNA methylation (Walsh
et al., 1998).564 Molecular Cell 56, 564–579, November 20, 2014 ª2014 ElsevierSpecification of PGCs occurs at E7.25 in response to BLIMP1,
PRDM14, and AP2g, which also initiates epigenetic reprogram-
ming (Magnu´sdo´ttir et al., 2013; Nakaki et al., 2013). Notably,
there is comprehensive erasure of histone H3 lysine 9 dimethyl
mark (H3K9me2), followed by genome-wide DNA demethylation
and erasure of genomic imprints between E8.5–E11.5 (Hajkova
et al., 2008, 2002; Seisenberger et al., 2012). Genomic imprints
are reestablished during gametogenesis and subsequently
play an essential role during development (McGrath and Solter,
1984; Surani et al., 1984). Epigenetic reprogramming and global
DNA demethylationwithout the erasure of imprints also occurs at
E0.5–E3.5 during development of blastocysts (Borgel et al.,
2010).
At the onset of global DNA demethylation in PGCs, PRMT5, a
highly conserved arginine methyltransferase, translocates from
the cytoplasm to the nucleus at E8.5, and during preimplanta-
tion development at the 4-cell stage (Ancelin et al., 2006; Tee
et al., 2010). PRMT5 catalyzes the symmetric dimethylation of
arginine residues including arginine 3 of the histones H2A and
H4 (H2A/H4R3me2s), a repressive histone modification (Bran-
scombe et al., 2001; Pal et al., 2004), and of other diverse nuclear
and cytoplasmic substrates. This includes Sm proteins in neural
progenitors, which are required for RNA splicing and p53 (Bezzi
et al., 2013; Jansson et al., 2008; Zhao et al., 2009). Loss of
PRMT5 is early embryonic lethal at E6.5, and is essential for
the derivation and maintenance of pluripotent ESCs (Tee et al.,
2010).
In the germline, PRMT5 interacts with BLIMP1, a key regulator
of PGC specification, which may facilitate its nuclear import at
E8.0, resulting in high levels of H2A/H4R3 methylation in
PGCs (Durcova-Hills et al., 2008). At E11.5, PRMT5-BLIMP1
translocate back to the cytoplasm with a consequent decrease
of H2A/H4R3me2s modification, as DNA methylation reaches
basal levels in PGCs (Ancelin et al., 2006). In the zygote,
PRMT5 is maternally inherited, followed by activation of embry-
onic Prmt5 at the two- to four-cell stage. PRMT5 relocates pre-
dominantly to the nucleus in four- to eight-cell-stage embryos
(Tee et al., 2010). Thus, PRMT5 resides in the nucleus in early
blastomeres at the onset of global DNA demethylation that rea-
ches basal levels in blastocysts at E3.5–E4.5 (Smith et al.,
2012). PRMT5 relocates back to the cytoplasm when de novoInc.
Molecular Cell
PRMT5 Suppresses TEs during DNA DemethylationDNA methylation and maintenance resume in postimplantation
epiblast cells.
DNA methylation is important for the repression of TEs, which
comprise 40% of the mammalian genome; their overexpression
can induce apoptosis and senescence due to their endonu-
clease activity and random transpositions (Belgnaoui et al.,
2006; Wallace et al., 2008). Global erasure of DNA methylation
in PGCs and embryos could cause activation of TEs and affect
genome integrity (Burns and Boeke, 2012; Walsh et al., 1998).
Of note, there is a transient upregulation of TEs at the two-cell
stage during the transition from ‘‘zygote to embryo’’ develop-
mental program (Fadloun et al., 2013; Peaston et al., 2004).
In the germline, a key mechanism for the repression of TEs is
through Piwi-interacting small RNAs (piRNAs) acting primarily
through de novo DNA methylation (Aravin et al., 2008), which is
initiated at E12.5. Thus, additional mechanisms for the repres-
sion of TEs are probably required in early PGCs, and during pre-
implantation development, to coincide with the comprehensive
erasure of DNA methylation.
Here we specifically investigated the role of PRMT5 in PGCs
and preimplantation embryos at the onset of DNA demethyla-
tion. We found that the H2A/H4R3me2s modification catalyzed
by PRMT5 was enriched on the LINE1 and IAP TEs of early
PGCs. Consequently, conditional loss of PRMT5 resulted in
loss of H2A/H4R3me2s and upregulation of TEs, apoptosis of
PGCs, and complete male and female sterility in otherwise viable
adults. Similarly, depletion of maternally inherited and zygotic
PRMT5 in preimplantation embryos caused an upregulation of
IAP. In PGCs, PRMT5 relocates back to the cytoplasm at
E11.5, where it has a different role in piRNA-mediated silencing
of TEs through methylation of PIWI proteins (Vagin et al., 2009).
This study demonstrates that nuclear PRMT5 is crucial for sup-
pressing TEs in PGCs and preimplantation embryos at the time
of global DNA demethylation.
RESULTS
Loss of PRMT5 in PGCs Results in Male and Female
Sterility
We previously showed that PRMT5, which is localized in the
cytoplasm of all postimplantation cells, translocates to the nu-
cleus following PGC specification at E8.0–8.5 onward (Ancelin
et al., 2006), which prompted us to examine the role of nuclear
PRMT5 during PGC development.
To delete PRMT5 in PGCs, we generated a Prmt5 conditional
allele (Prmt5flox) and crossed Prmt5flox/flox mice with Blimp1-
Cre-BAC transgenic mice (Ohinata et al., 2005) (see Figures
S1A–S1D available online), and followed development of
Prmt5 mutant germ cells beyond E8.5 (Figure 1A). We initially
found alkaline phosphatase (AP)-positive mutant PGCs in
numbers similar to those in control embryos at E8.5 (41 versus
47 at 0–4 somite stage; 81 versus 88 at 5–10 somite stage; Fig-
ure S1E). While PRMT5 was still detectable in the majority of
mutant PGCs at E8.5 (89% versus 99%; Figure 1B), their levels
declined progressively thereafter as they migrated to the go-
nads. Indeed, PRMT5 was depleted in the majority of mutant
PGCs by E10.5 but, as expected, not in the surrounding somatic
cells (13% versus 99%; Figure 1B). While the mutant embryosMolecdeveloped to apparently normal adulthood (Figures S1F and
S1G and see below), both males and females were sterile,
with significantly smaller testes and ovaries that lacked germ
cells (Figure 1C). These observations establish unequivocally
that Prmt5 is essential for the development of PGCs. We set
out to investigate why PRMT5 is essential in PGCs after their
specification.
The Histone Modification H2A/H4R3me2s Is Lost in
Prmt5 Mutant PGCs
Next, we established that the enrichment of PRMT5 in the nu-
cleus occurred in most PGCs by E8.5 (E7.75, 62%; E8.5,
99%; Figures 1D and S2A), where it persisted as the PGCs
migrated and colonized the genital ridge at E10.5 (98%; Fig-
ures 1D and S2A). PRMT5 relocates back to the cytoplasm after
E11.5, and was rarely detected in the nucleus after E11.5 (E11.5,
6%; E12.5, 0.4%; Figures 1D and S2A). Notably, this transient
presence of PRMT5 in the PGC nucleus at E8.0–E11.0 occurs
following erasure of H3K9me2 and coincides with comprehen-
sive epigenetic reprogramming in PGCs, including global DNA
demethylation (Hackett et al., 2013).
The translocation of PRMT5 to the nucleus is accompanied by
an enrichment of the H2A/H4R3me2s modification in PGCs,
which occurs progressively from E8.5 to E10.5, and persists until
E12.5 in PGCs (E8.5, 51%; E10.5, 83%; Figures 1E and S2B).
By contrast, this chromatin modification diminished significantly
and rapidly in Prmt5 mutant PGCs, and was virtually undetect-
able by E12.5 (E10.75; 49% versus 99%, E12.5; 4% versus
93%, Figure 2A).
Next we examined if the loss of H2A/H4R3me2s in PGCs had
an effect on the dynamic changes of other histone modifications
during epigenetic reprogramming of PGCs; this includes the loss
of H3K9me2 and an increase in the intensity of H3K27me3 (Haj-
kova et al., 2008). There were no detectable effects however on
these modifications on a global level in mutant PGCs at E10.75–
E12.5 (Figures 2B, 2C, and S2C). Other histone modifications,
including H3K9ac and H3K9me3, were also unchanged in
mutant PGCs at E11.5 (Figure S2C). Thus, the loss of PRMT5
in PGCs specifically affects the H2A/H4R3me2s modification,
at least on a global level.
Prmt5 Mutant PGCs Undergo Apoptosis
As noted above, loss of PRMT5 in PGCs results in complete
sterility in both males and females. To determine when precisely
mutant PGCs are affected, we first examined the total number of
PGCs by AP staining at E11.5, and found that the Prmt5 mutant
PGCs were reduced in both male and female embryos (Figures
3A and S3A). Further analysis using Blimp1Cre;Prmt5flox/
mice harboring an Oct4DPE-GFP reporter gene (GOF) (Yeom
et al., 1996) showed that 87% of the mutant PGCs had lost
PRMT5 by E10.5 (Figure 1B). Moreover, flow cytometry analysis
for GOF-positive cells revealed a reduction in the number of
Prmt5 mutant PGCs to 59% compared to those in control litter-
mates at E11.5 (399 versus 682; n = 10, n = 25 embryos, p < 0.05)
(Figure 3B). By E15.5–E16.5, none of the Prmt5 mutant PGCs
survived in either male or female embryos (Figures 3C and 3D),
or in the postnatal testis (9 dpp and 6 weeks; Figures S3B–
S3D). However, the somatic cells formed apparently normalular Cell 56, 564–579, November 20, 2014 ª2014 Elsevier Inc. 565
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Figure 1. Deletion of Prmt5 in the Germline using Blimp1-Cre Results in Male and Female Sterility
(A) A schematic of PGCs development (E6.5–E12.5) represents the following: nuclear-cytoplasmic translocation of PRMT5, increase of H2A/H4R3me2s
modification, progressive erasure of DNA methylation, and the initiation of Blimp1-Cre expression to induce deletion of nuclear Prmt5.
(B) Detection of PRMT5 (red) by immunofluorescence (IF), and of the PGC markers OCT4 (E8.5; green) or SSEA1 (E10.5; green) in genital ridges. Right graph
shows the number of PRMT5-positive PGCs (% PRMT5-positive/PGC marker-positive cells). At E8.5, 89% of mutant PGCs were PRMT5 positive (57/64), and at
E10.5 13% of mutant PGCs were PRMT5 positive (9/70). Scale bar, 20 mm. The arrowheads mark PGCs.
(C) (Left panel) Testis and ovary from adult mutants (right) are considerably smaller than from control littermate (left). Scale bar, 2 mm. (Right panel) Hematoxylin
and eosin staining of sections from adult testis and ovary shows a lack of sperm and oocytes in mutants. Scale bar, 100 mm. The genotype of the control is
Blimp1Cre;Prmt5flox/+ and the mutant is Blimp1Cre;Prmt5flox/ in (B) and (C).
(D) The number of PGCs (in %) with nuclear PRMT5 detected by IF at E7.5–E12.5 in wild-type embryos.
(E) The number of PGCs with similar or higher level of H2A/H4R3me2s detected by IF (Med/High, black, in %) in PGCs compared to surrounding somatic cells at
E8.5–E12.5.
See also Figures S1 and S2.
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Figure 2. Loss of Prmt5 in the Germline Results in Loss of H2A/H4R3me2s
(A) IF staining of genital ridges for H2A/H4R3me2s (red). PGCs were detected with antibodies against SSEA1 (green, E10.75) or GFP for GOF (green, E12.5).
Merged images are shown with DNA stained with DAPI (blue). (Right graph) Number of PGCs labeled with H2A/H4R3me2s (in%). At E8.5, 81% (21/26) of mutant
PGCswere H2A/H4R3me2s positive, which were reduced to 49% (50/102) at E10.75, and at E12.5 there were 4% (3/74) mutant PGCs that were positive for H2A/
H4R3me2s.
(B) IF staining of H3K27me3 (red) in genital ridges at E10.75. PGCs were detected with SSEA1 antibody (green).
(C) IF staining of H3K9me2 (red) in genital ridges at E10.75 shows a lack of this modification in PGCs. PGCs were detected with SSEA1 antibody (green).
Scale bar, 20 mm in (A)–(C). The arrowheads in (A)–(C) indicate examples of PGCs. The genotype of the control is Blimp1Cre;Prmt5flox/+, and the mutant is
Blimp1Cre;Prmt5flox/ in (A)–(C).
See also Figure S2.
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loss of mutant PGCs coincides with the rapid loss of H2A/
H4R3me2s modification from the nucleus of Prmt5 null PGCs
from E10.75 onward.
To determine the cause of the loss of PGCs in PRMT5 mu-
tants, we examined the rate of cell proliferation and cell death
at E11.5 by immunostaining of phosphorylated histone H3
Ser10 (H3S10ph), a marker of mitosis. This showed 5% of the
PGCs were positive in control embryos (18/344) compared to
19% (22/113) in Prmt5 mutants (Figure 3E). Further, we stained
for the proliferation marker Ki67 nuclear antigen, which is en-
riched in S, G2, and M phases but low in G0 and G1 (Gerdes
et al., 1984). This showed that 44% (29/66) of mutant PGCs
have low Ki67 staining compared to 19% (29/157) of control
germ cells (Figure 3F). These results suggest that relativelyMolecmore Prmt5 mutant germ cells are in G0/G1 phase or arrested
in cell cycle. The small number of surviving mutant PGCs prog-
ress through the cell cycle asynchronously, which prevents
detailed analysis. Nevertheless, these combined data suggest
that there is a heterogeneous population of Prmt5 mutant
PGCs with defects in cell-cycle regulation.
Next, we analyzed the rate of cell death by TUNEL labeling,
which showed that a greater number of mutant PGCs were un-
dergoing apoptosis from E11.5 onward compared to controls
(15% versus 0%; Figure 3G). Consistently, live imaging for
24 hr of genital ridges ex vivo from E11.5 control and Prmt5
mutant embryos with the GOF reporter transgene revealed that
the number of mutant PGCs declined progressively as they frag-
mented and disappeared (Figures 3H and S3E; Movie S1 and
Movie S2). Taken together, these results suggest that the lossular Cell 56, 564–579, November 20, 2014 ª2014 Elsevier Inc. 567
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PRMT5 Suppresses TEs during DNA Demethylationof PGCs in Prmt5mutants is caused by apoptosis and cell-cycle
deregulation.
DNA Damage Response Genes Are Upregulated in
Prmt5 Mutant PGCs
To determine the consequences of the loss of H2A/H4R3me2s
modification in Prmt5 mutant PGCs, we analyzed their tran-
scriptome by microarrays at E11.5. Surprisingly, only 32 out
of 22,166 probes showed significant differential gene expres-
sion changes (adj.p < 0.05) (Table S1). We sought more
comprehensive information by performing RNA-Seq analysis
on control and mutant PGCs at E11.5 (Tang et al., 2010). Again,
we found that only 422 genes were differentially expressed (p <
0.05), among which 201 genes were upregulated (>1.24-fold)
and 221 were downregulated (<0.82-fold) (Table S2). Notably,
we detected upregulation of the p53 signaling genes (Cdkn1a,
Mdm2, Ccng1) and DNA damage response genes (Ercc5, Btg2,
Rev1) in the Prmt5mutant PGCs (Figure 4A; Table S1 and Table
S2), while the downregulated genes were categorized to RNA
processing (Prpf31, Exosc2, Zranb2) and DNA metabolic pro-
cess (Fbxo18, Recql, Lig3). Gene ontology (GO) and Kyoto
Encyclopedia of Genes and Genomes (KEGG) analysis showed
upregulation of peptidase regulator activity, DNA damage
response, and p53 class mediators, as well as of the spliceo-
some complex in Prmt5 mutant PGCs (Figures S4A and S4B).
The splicing defects and the activation of the p53-signaling
pathway upon loss of PRMT5 are consistent with the observa-
tions in other cell types such as neural progenitor cells (Bezzi
et al., 2013; Figure S4E). We validated the microarray and the
RNA-Seq results by quantitative RT-PCR (qPCR) for selected
genes in E11.5 PGCs (Figure 4B). Importantly, some key germ-
line genes, including POU5F1 (Oct4) and Dppa3 (stella) were
not affected in Prmt5mutant PGCs (Figures 4B and S4C; Table
S1 and Table S2), which we confirmed by immunostaining for
OCT4, VASA, and DAZL (Figures 4C and 4D). Collectively,
these results indicate that among the key effects of loss of
PRMT5 in PGCs is the induction of DNA damage response
and p53 signaling genes, which is consistent with their
apoptotic response. Of note, the loss of the repressive H2A/
H4R3me2s modification did not result in a global deregulation
of transcription in PGCs.Figure 3. Prmt5 Mutant PGCs Undergo Apoptosis
(A) Staining of E11.5 genital ridges for alkaline phosphatase (AP, seen as brown)
(B) The number of PGCs at E11.5 determined by flow cytometry for SSEA1/GOF
(C) AP staining (top) and IF staining of GFP (bottom) in E15.5 female gonads. Merg
GFP (for GOF transgene, green). Note a lack of mutant germ cells in the gonads
(D) IF staining of the late germ cell marker MVH (mouse vasa homolog, white) sho
pane). Scale bar, 50 mm.
(E) IF staining for the mitosis marker H3S10ph (red) in genital ridges at E11.5. PGC
bar, 10 mm. The number of PGCs that were labeled for H3S10ph is shown on the
(F) IF staining for the mitosis marker Ki67 (red) in genital ridges at E11.5. PGCs ar
The number of PGCs in control and Prmt5mutant embryos (in %) that were posit
(G) TUNEL assay (red) to visualize apoptosis in genital ridges at E11.5. Scale bar,
(green). The number of PGCs that were labeled in the TUNEL assay are shown o
(H) GFP-positive PGCs in the field of view during 24 hr time-lapse imaging of E1
compared to controls (blue), in which the numbers fluctuated but did not change s
is Blimp1Cre;Prmt5flox/ in (A)–(H).
See also Figure S3, Movie S1 (Mutant), and Movie S2 (Control).
MolecTransposable Elements Are Upregulated in Prmt5
Mutant PGCs
PGCs are likely to be vulnerable to the expression of TEs, espe-
cially during major epigenetic changes, including global DNA de-
methylation and the loss of H3K9me2, both of which are involved
in the repression of TEs (Di Giacomo et al., 2013; Hajkova et al.,
2002). Overexpression of TEs can have major genome-destabi-
lizing effects in association with abnormal cell-cycle progression
(Belgnaoui et al., 2006). TEs-induced mutations could also be
detrimental for subsequent development, especially if it occurs
repeatedly during the subsequent germline cycles. As Prmt5
mutant PGCs showed upregulation of DNA damage-response
genes, we examined the RNA-Seq data of E11.5 PGCs and
found that IAP-LTR1 is one of the most highly upregulated TEs
in Prmt5mutant PGCs (Figure 5A; Table S3). IAP-LTR1 is among
the most active and abundant class of IAP elements whose
expression can compromise genome integrity through random
mutations following transpositions (Qin et al., 2010).
Since the PGC population is developmentally heterogeneous,
and the H2A/H4R3me2s modification is lost in 49% of mutant
PGCs by E10.75, we examined the expression of TEs by qRT-
PCR analysis on single-cell cDNAs from PGCs. Remarkably,
despite the heterogeneity of expression levels of TEs in single
PGCs, the bulk of Prmt5 mutant PGCs at E11.5 showed an
3-fold upregulation of IAP-LTR (p < 0.05). This suggests that
among the mutant PGCs, some of them have very high levels
of IAP-LTR expression. In addition, the open reading frame
(ORF)2 of LINE-1 which encodes an endonuclease and a reverse
transcriptase showed5-fold higher expression inmutant PGCs
(p < 0.05) compared to controls (Figure 5B). The LINE-1 50 UTR
and IAP-GAG were apparently not significantly affected, which
may be due to technical reasons following the generation of
30 biased cDNAs during single-cell reverse transcription amplifi-
cation (Tang et al., 2010). The expression of short interspersed
nonrepetitive elements B1 (SINE-B1) was also seemingly not
affected (p = 0.85; Figure 5B). Notably, in E12.5 PGCs, we de-
tected a 6-fold increase of LINE-1 ORF2 in E12.5 mutant PGCs
(Figure S5A). However, the levels of IAP-GAG seemed to be
less affected, probably owing to the heterogeneity among
mutant cells such that the surviving E12.5 mutant PGCs might
represent a minor population that have yet to exhibit the effects, a marker of PGCs. Scale bar, 0.5 mm.
-positive cells. Shown are the mean values ± SE (Student’s t test, *p < 0.05).
ed images are shown with DNA stained with DAPI (blue) and PGCs stained with
. Scale bar, 100 mm.
ws a lack of staining in E16.5 male mutant PGCs in gonads (bottom right hand
s are costained with antibodies against GFP that recognizes GOF (green). Scale
right (in %).
e costained with GFP antibody that recognizes GOF (green). Scale bar, 10 mm.
ive for Ki67 are shown in black; cells with low or no staining are shown in gray.
10 mm. PGCs were costained with antibodies against GFP for GOF transgene
n the right (in %). The arrowheads in (E) and (F) indicate examples of PGCs.
1.5 genital ridges. Note a steady decline in the number of mutant PGCs (green)
ignificantly. The genotype of the control isBlimp1Cre;Prmt5flox/+ and themutant
ular Cell 56, 564–579, November 20, 2014 ª2014 Elsevier Inc. 569
AC D
B
Figure 4. The Loss of PRMT5 in PGCs Induces p53 Signaling and DNA Damage Response Genes
(A) A heatmap of selected up- and downregulated genes in E11.5 PGCs from RNA-Seq analysis. Cluster dendogram for two biological replicates of each ge-
notype is shown on top. Note that p53 signaling genes and DNA damage response genes are upregulated (red) in the mutant, while primary metabolic process
and RNA processing genes are downregulated (blue).
(B) qRT-PCR analysis of selected genes in E11.5 PGCs (control, white; mutant, black). Shown are themean values ± SE. Significance is shown by Student’s t test:
**p < 0.01, *p < 0.05.
(C) IF staining of DAZL (late germ cell marker, red) in genital ridges at E11.5. PGCs were detected with antibodies against SSEA1 (green). Merged images are
shown with DNA stained with DAPI (blue). The ratio of DAZL-positive PGCs in SSEA1-positive PGCs (in %) was determined (controls, white; mutants, black).
(D) IF staining of MVH (late germ cell marker, red) in genital ridges at E11.5. The ratio of MVH-positive PGCs in GFP positive (green) PGCs (in%) was determined.
Scale bar, 20 mm in (C) and (D). The arrowheads in (C) and (D) indicate examples of PGCs. The genotype of the control is Blimp1Cre;Prmt5flox/+, and the mutant is
Blimp1Cre;Prmt5flox/ in (A)–(D).
See also Figure S4 and Table S2.
Molecular Cell
PRMT5 Suppresses TEs during DNA Demethylationof the Prmt5 mutation (Figure S5A). Indeed, the development of
individual PGCs does not occur synchronously, within or be-
tween embryos.570 Molecular Cell 56, 564–579, November 20, 2014 ª2014 ElsevierNext, we looked for the presence of L1ORF1p and IAP-GAG
proteins by immunostaining of E11.5 PGCs with specific anti-
bodies. This showed a significant increase in the levels ofInc.
Molecular Cell
PRMT5 Suppresses TEs during DNA DemethylationL1ORF1p in a substantial number of Prmt5 mutant PGCs
compared to the control (71% versus 10%; Figure 5C). The
levels of L1ORF1p expression in Prmt5 mutant PGCs increased
progressively from E10.5 to E12.5 (Figure 5C). In addition, IAP-
GAG was more abundant in mutant PGCs at E11.5 (56% versus
23%; Figure 5D) and in surviving mutant germ cells at E12.5.
Wild-type PGCs rarely expressed detectable levels of IAP-
GAG (Figure 5D). This shows that both the IAP and LINE-1 ele-
ments are derepressed in mutant PGCs, which coincides with
the progressive loss of the H2A/H4R3me2s modification.
To test whether this upregulation of TEs expression and pro-
teins has any consequence, we stained E12.5 genital ridges for
gH2AX, which is a marker for DNA double-strand breaks. We
found that the mutant PGCs that contained bright and greater
number of gH2AX nuclear foci compared to control (Figure S5B).
Accordingly, the mean intensity of gH2AX in mutant GFP-posi-
tive PGCs was 1.3-fold higher than in control. Combined with
the upregulation of DNA damage response genes in mutant
PGCs, this result suggests that the upregulation of TEs may
cause DNA lesions in Prmt5 mutant germ cells (Figures S4A
and S5B).
We asked if the loss of PRMT5 has an effect on DNA methyl-
ation of repetitive elements in PGCs. While the global erasure
of DNA methylation in PGCs reaches basal levels by E13.5,
some repetitive elements such as IAP are only partially demethy-
lated (Hackett et al., 2013). There was little effect on the status of
DNA methylation of IAP and LINE1 elements in Prmt5 mutant
PGCs by bisulphite genomic sequencing of E11.5 PGCs, except
for a slightly higher extent of demethylation of IAP in mutant
compared to wild-type PGCs (average level 76% versus 81%;
n = 5, Figure 5E). There was no reduction in DNA methylation
of LINE1 in Prmt5 mutant PGCs, suggesting that the loss of
DNA methylation was not a major cause for the elevation of
IAP and LINE-1 expression (Figure 5E). Indeed, the expression
of LINE1 was not upregulated despite high levels of demethyla-
tion in wild-type PGCs. There was also no detectable effect on
the expression of DNA methyltransferase 1 (DNMT1) in Prmt5
mutant PGCs at E11.5 (Figure S5C). This indicates a lack of
significant correlation between overall changes in DNA methyl-
ation levels and the expression of LINE1 and IAP, which is also
not due to any additional loss of DNA methylation from these el-
ements in Prmt5mutant PGCs. This supports the possibility that
the translocation of PRMT5 from the cytoplasm to the nucleus at
E8.5, and the associated H2A/H4R3me2s modification de-
tected in the PGC nuclei, might have a role in the repression of
LINE1 and IAP.
H2A/H4R3me2s Is Enriched at IAP and LINE-1 in PGCs
The enrichment of the H2A/H4R3me2s repressive modification
in PGCs might have a specific role in the repression of TEs, as
this mark is generally implicated in gene repression (Xu et al.,
2010). This modification was detected by immunofluorescence,
concomitantly with the translocation of PRMT5 to the nucleus at
E8.5 in PGCs (Figures 1D, 1E, S2A, and S2B).
To check for the presence of the H2A/H4R3me2smodification
on TEs, we carried out chromatin immunoprecipitation (ChIP)
analysis for this mark on LINE1 and IAP in PGCs. Indeed, we
found that both LINE1 and IAP are enriched for the H2A/MolecH4R3me2s modification at E10.5–E11.5 in PGCs (Figure 5F).
Subsequently, it is lost in male PGCs at E13.5 following translo-
cation of PRMT5 to the cytoplasm at E11.5. The specificity of
this modification was evident by comparison with the negative
control regions at the Oct4 and Nanog loci with a highly dimin-
ished signal. Further, LINE1 and IAP are not enriched for the
modification in male PGCs at E13.5. It is technically not possible
to similarly analyze Prmt5 mutant PGCs due to their extremely
low numbers (400 PGCs/embryo at E11.5, Figure 3B). We did
not, however, detect the H2A/H4R3me2s modification in mutant
PGCs by immunofluorescence at E12.5 (Figure 2A), which indi-
rectly implicates the loss of this modification on TEs. The com-
bined data indicate that the enrichment of H2A/H4R3me2s
modification in PGCs coincides with the entry of PRMT5 into
the nucleus during global DNA demethylation in E8.5–E11.5
PGCs. Notably, the H2A/H4R3me2s enrichment on LINE1 and
IAP precedes expression of piRNAs and PIWI proteins in male
germ cells at E12.5–E15.5 (Aravin et al., 2008; Kuramochi-Miya-
gawa et al., 2004). As discussed later, loss of cytoplasmic
PRMT5 in early postimplantation epiblast has a negligible effect
on TE expression owing to the resumption of DNAmethylation in
these cells (see later).
In summary, the loss of H2A/H4R3me2s in Prmt5 mutant
PGCs occurs at E10.5–E11.5 followed by upregulation of
LINE1 and IAP elements at E11.5–E12.5 (Figures 2A and 5B–
5D). Our results suggest that PRMT5 and the histone modifica-
tion H2A/H4R3me2s are required for the suppression of TEs
during extensive reprogramming, including loss of H3K9me2
and global DNA demethylation in PGCs.
PRMT5 Represses Transposable Elements during
Preimplantation Development
In principle, it is possible that PRMT5 might have a similar role
elsewhere during global DNA demethylation of the genome.
We took the opportunity to test this idea during another major
epigenetic reprogramming event through development of the
mouse zygote to the blastocyst stage, which is accompanied
by global DNA demethylation (Smith et al., 2012). Our observa-
tion on PGCs prompted us to examine the role of maternally in-
herited and zygotic PRMT5 during preimplantation development
(Tee et al., 2010).
In preimplantation embryos, PRMT5 is present in the cyto-
plasm of the zygote and two-cell-stage embryos, but it localizes
to the nucleus at the four- to eight-cell stage and persists there
until the early E3.5 blastocyst stage (Figure 6A). Concomitantly
with the nuclear localization of PRMT5, we could detect enrich-
ment of H2A/H4R3me2s in the nucleus, particularly in eight- to
sixteen-cell-stage embryos; prior to this, there are relatively
low levels of this modification detectable at the two-cell stage
(Figure S6A). Thereafter, PRMT5 is mostly cytoplasmic in the
E4.5 epiblast cells of developing embryos, concurrently with
the initiation of de novo DNA methylation in epiblast cells,
although it remains in the nucleus of trophectoderm (TE) cells
that are relatively hypomethylated (Chapman et al., 1984).
We had previously shown that embryonic development
following the loss of zygotic PRMT5 after an intercross between
Prmt5+/ mice, was morphologically indistinguishable from
wild-type E3.5 blastocysts (Tee et al., 2010). Consistently,ular Cell 56, 564–579, November 20, 2014 ª2014 Elsevier Inc. 571
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Figure 5. Transposable Elements Are Upregulated in the Absence of PRMT5 in PGCs
(A) Top ten upregulated TEs in E11.5 mutant PGCs identified in the RNA-seq analysis. Mutant PGC values were compared to control PGC values and are shown
as fold change (Mutant/Control).
(legend continued on next page)
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Molecular Cell
PRMT5 Suppresses TEs during DNA Demethylationzygotic Prmt5 mutant blastocysts have OCT4-positive cells in
the inner cell mass (ICM) and CDX2-positive TE cells (Fig-
ure S6B). Notably, there were no significant changes in the
expression of IAP and LINE1 elements in zygotic Prmt5 mutant
embryos at the eight-cell stage and blastocysts (Figures S6C–
S6E).
We considered that the maternally inherited PRMT5 could
to some extent compensate for the zygotic loss of PRMT5 dur-
ing preimplantation development (Figure S6F). We therefore
depleted the oocytes of the maternally inherited PRMT5,
by generating an oocyte-specific Prmt5 mutant female of
Prmt5flox/ with Zp3-Cre (Zp3, zona pellucida glycoprotein 3)
that is active in maturing oocytes (Figure 6B) (de Vries et al.,
2000). The loss of maternally inherited PRMT5 in oocytes did
not have an effect on their properties or development, since
we found these females to be fertile when mated with the wild-
type males (Figures S1G and S6G).
Next we examined the development of preimplantation
embryos that are depleted of both maternally inherited as
well as zygotic PRMT5 by mating Zp3Cre;Prmt5flox/- mice with
Prmt5+/ males (Figure 6B). These embryos were collected at
E2.5 and cultured for 2 days in vitro. Mutant embryos
(Prmt5mat/) showed slightly higher L1Orf1p expression, which
was not significant compared to controls (Prmt5mat/+) (Fig-
ure 6C, 1:1.2, p = 0.19). However, IAP-GAG expression in the
ICM of blastocysts was significantly elevated in Prmt5 mutant
embryos (Prmt5mat/) (1:2.1, p < 0.01) (Figure 6D). At E4.5
in vivo, mutant embryos (Prmt5mat/) have a reduced number
of cells compared to control (Prmt5mat/+), and they do not
form of a blastocoel and appear to collapse, which likely causes
early embryonic lethality (Figure S6H). This suggests that PRMT5
also plays an important role in the suppression of specific TEs in
preimplantation embryos during DNA demethylation.
Role of PRMT5 in Embryonic Stem Cells in ‘‘2i’’ Culture
Conditions
We among others showed that ESCs when cultured in a chemi-
cally defined condition using inhibitors of GSK3 and MEK (2i)
(Ying et al., 2008) have a hypomethylated status compared to
ESCs in serum (Leitch et al., 2013). We tested whether PRMT5
has a similar role in suppressing TEs in ESCs cultured in 2i
medium. PRMT5 in ESCs cultured in standard medium with
serum is almost exclusively in the cytoplasm (Tee et al., 2010),
but we found that the transfer of ES to 2i medium resulted in
the detection of PRMT5 in the nucleus, consistent with DNA hy-(B) Single-cell qPCR analysis of TEs as indicated fromE11.5 control (gray) andmut
The data are combined as mean values ± SE of all single cells as shown in the c
(C) IF staining of L1Orf1p (red) in E10.5–E12.5 genital ridges and quantification o
detected with GFP antibody for GOF (green). Scale bar, 10 mm.
(D) IF staining of IAP-GAG (red) in E11.5 and E12.5 genital ridges and quantificatio
10 mm. The arrowheads in (C) and (D) indicate examples of PGCs.
(E) DNA methylation changes in IAPs determined by bisulfite sequencing with FA
#5) andmutant embryos (#6–#10). DNAmethylation of E11.5 PGCs from one litter
(#11–#16). The right graph shows the average level of methylation ± SD at the IA
(F) ChIP with wild-type PGCs from E10.5, E11.5, and E13.5male using a H2A/H4R
Oct4 and Nanog locus served as negative controls. Data are from biological dup
Blimp1Cre;Prmt5flox/ in (A)–(E).
See also Figure S5 and Table S3.
Molecpomethylation (Leitch et al., 2013), albeit only in 20%–30% of
the ESCs. It is possible that nuclear-cytoplasmic translocation
occurs dynamically in all individual cells (Figure S7A).
To examine the consequences of loss of PRMT5 in ESCs
in ‘‘2i,’’ we crossed the Prmt5flox/flox mice to R26Cre-ERT
(R26Cre) mice and derived ESCs in 2i condition (Figure S7B;
Vooijs et al., 2001). Following treatment of cells with 4-hydroxy-
tamoxifen (OHT), the floxed Prmt5 allele was efficiently excised
by R26Cre after 24 hr, followed by a decline in the Prmt5
mRNA levels (0.18-fold) (Figures S7B and S7E). These
R26Cre;Prmt5flox/flox cells died 5 days after OHT treatment, while
control EtOH treatment of R26Cre;Prmt5flox/flox or OHT-treated
heterozygous line (R26Cre;Prmt5flox/+) did not show any detect-
able defects (Figure S7C). While we detected upregulation of
IAP-Gag (1.8-fold) and not of L1Orfp (1.3-fold) in the mutant
cells (Figure S7E), there was also no detectable increase in
IAP-GAG protein (mean intensity, 1:1.02, Figure S7F). Indeed,
we also neither detected any significant decrease in the global
H2A/H4R3me2s modification, nor specifically on the TEs (Fig-
ures S7G and S7H). It is possible that Prmt7, a related family
member, might compensate for the loss of Prmt5. Since we
detected splicing defects in mutant ESCs, this might account
for the death of these ESCs (Figure S7D; Bezzi et al., 2013).
Loss of Cytoplasmic PRMT5 in Early Postimplantation
Epiblast Cells
Development of the postimplantation epiblast is accompanied
by DNA methylation, when PRMT5 translocates to the cyto-
plasm. To check whether the predominantly cytoplasmic
PRMT5 in epiblast has any role in the repression of TEs, we
examined these cells that were depleted of PRMT5 specifically
at E5.5–E6.5 by mating Prmt5flox/flox mice with Sox2-Cre trans-
genic mice (Hayashi et al., 2002) (Figure S7I). Examination of
these cells that were depleted of PRMT5 at E6.5 showed no
significant expression of IAP-GAG by immunostaining (Fig-
ure S7J). Furthermore, qRT-PCR analysis of dissected epiblasts
at E7.5 confirmed that both IAP and LINE1 showed no significant
change in their expression in the Prmt5 mutant epiblast (Fig-
ure S7K). However, as with the mutant ESCs, we detected
splicing defects in the mutant epiblast cells (Figure S4E), which
is consistent with a previous report (Bezzi et al., 2013).
Loss of PRMT5 did not, however, affect specification of PGCs,
since we detected PGCs in E7.75 mutant embryos as judged by
the detection of PGCmarkers, AP2g and TNAP (Figures S7L and
S7M). These results suggest that DNA methylation rather thanant (black) FACS-sorted PGCs (GOF/SSEA1). Each bar represents a single cell.
hart on the right. Significance is shown by Student’s t test, *p < 0.05.
f PGCs that shows an increase of L1Orf1p fluorescence intensity. PGCs were
n of PGCs that show an increase in IAP-GAG fluorescence intensity. Scale bar,
CS-sorted PGCs (GOF/SSEA1) from E11.5 genital ridges from five control (#1–
mate control and mutant embryo were tested for the LINE1, Dazl and Sfi1 locus
P, LINE1, Dazl, and Sfi1 loci.
3me2s antibody and IgG, respectively. ChIP-qPCR results ± SE are shown. The
licates. The genotype of the control is Blimp1Cre;Prmt5flox/+, and the mutant is
ular Cell 56, 564–579, November 20, 2014 ª2014 Elsevier Inc. 573
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Figure 6. Prmt5 Is Required for the Suppression of TEs in Preimplantation Embryos
(A) IF staining of OCT4 (green) and PRMT5 (red) in wild-type two-cell to blastocyst-stage preimplantation embryos (stages are indicated). Note that PRMT5 is
detected in the nucleus from four-cell-stage embryos. TE, trophectoderm; ICM, inner cell mass; scale bars, 20 mm.
(legend continued on next page)
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Molecular Cell
PRMT5 Suppresses TEs during DNA DemethylationPRMT5 in the postimplantation epiblast cells is likely to repress
TEs. Thus, loss of cytoplasmic PRMT5 has no marked effect
on the expression of TEs.
DISCUSSION
This study demonstrates that PRMT5 is indispensable during
extensive resetting of the epigenome in early PGCs, and in pre-
implantation development. In both instances, PRMT5 relocates
from the cytoplasm to the nucleus concomitantly with the onset
of comprehensive DNA demethylation. Notably, there is also
comprehensive erasure of H3K9me2 following specification of
PGCs (Hajkova et al., 2008), which has been shown to suppress
LINE1 during spermatogenesis (Di Giacomo et al., 2013). These
epigenetic changes in the DNA and chromatin in early PGCs are
conducive for the expression of TEs prior to the piRNA biosyn-
thesis; nuclear PRMT5 seems to have a role in the suppression
of TEs at this time.
PRMT5 catalyzes the repressive chromatin modification H2A/
H4R3me2s, which is detected on the LINE1 and IAP in PGCs.
Loss of PRMT5 results in the loss of H2A/H4R3me2s and upre-
gulation of IAP and LINE1, suggesting that nuclear PRMT5 has
a role in the repression of TEs. Similarly, loss of maternally in-
herited and zygotic PRMT5 results in upregulation of TEs. In
contrast, loss of cytoplasmic PRMT5 in the postimplantation
epiblast did not cause a significant upregulation of TEs, where
DNA methylation is likely involved in their repression (Walsh
et al., 1998). The nuclear PRMT5-dependent mechanism of
TEs repression in the germline differs from the previously
described repression of TEs by small RNA-induced silencing,
by DNAmethylation, or constitutive repressive histone modifica-
tions (Kuramochi-Miyagawa et al., 2008; Rowe et al., 2010).
Notwithstanding, germline-specific loss of nuclear PRMT5 re-
sults in complete sterility of adult males and females. In mam-
mals, TEs are more active in the germline compared to somatic
lineages, and the loss of their suppression could affect fertility, as
shown in mutants of piRNA components and Tex19.1 (Carmell
et al., 2007; O¨llinger et al., 2008). This is especially likely at the
time of global DNA demethylation and loss of H3K9me2 that
could make PGCs more susceptible to misregulation of TEs.
Their deregulation could result in deleterious effects, including
high rate of illegitimate pairing between nonhomologous chro-
mosomes during meiosis, which triggers an apoptotic check-
point (Zamudio and Bourc’his, 2010), especially in female
PGCs that enter meiosis at E13.5.(B) Schematic diagram of the subcellular localization of PRMT5 (shown in orang
Zp3Cre is expressed during oocyte maturation. The mating scheme shows how t
experimental outline (bottom).
(C) IF staining of OCT4 (green) and L1Orf1p (red) in control (Prmt5mat/+) and mate
line indicates the ICM region. Scale bars, 20 mm. The fluorescence intensity of L1
mutant embryos. The data are from two independent experiments, and the relativ
embryos is shown. The right graph shows the mean intensity ± SD of all embryo
(D) IF staining of OCT4 (green) and IAP-GAG (red) in control (Prmt5mat/+) and ma
region is indicated by the dashed line. Scale bars, 20 mm. The fluorescence int
embryos and nine mutant embryos. The data are from two independent experime
intensity of control embryos is shown. The right graph shows the mean intensity
Student’s t test, **p < 0.01.
See also Figure S6.
MolecThe onset of global DNA demethylation is a significant feature
of PGCs and preimplantation embryos, but what precisely trig-
gers the relocation of PRMT5 from the cytoplasm to the nucleus
on both these occasions is unknown. PRMT5 has three nuclear
export signals but no nuclear localization signal (Gu et al.,
2012), suggesting that specific mediators might be involved in
the nuclear import, acting together with a block on the export
signal. These mediators could include BLIMP1 (a key regulator
of PGC specification) since PRMT5-BLIMP1 interaction was re-
ported previously (Ancelin et al., 2006), as are AJUBA and SNAIL
in the case of U2OS cells (Hou et al., 2008). The targeting of
PRMT5 to specific loci such as TEs remains to be elucidated.
Global DNA demethylation in actively dividing PGCs is poten-
tially conducive for TE expression and transpositions, which
would increase the vulnerability of PGCs to transpositions (Burns
and Boeke, 2012). However, there is no evidence to suggest that
DNA demethylation and H2A/H4R3me2s modification are func-
tionally interdependent in PGCs. For example, H2A/H4R3me2s
modification was still detectable on ‘‘imprinted’’ regions after
the erasure of DNA methylation in PGCs (Henckel et al., 2012).
Furthermore, while loss of PRMT5 and the H2A/H4R3me2s
modification did not affect DNA methylation of LINE1, expres-
sion of LINE1 was elevated in Prmt5 mutant PGCs. We propose
that the H2A/H4R3me2s mark accompanies and compensates
for the reduction in DNA methylation and the loss of H3K9me2
to repress TEs in PGCs. Moreover, the H2A/H4R3me2s modifi-
cation can function regardless of DNA demethylation to repress
gene expression (Henckel et al., 2012), potentially by inhibiting
RNA polymerase II binding as they show inverse relationship
on silenced loci in primary erythroid progenitors (Zhao et al.,
2009).
The repressive H3K9me2 histone modification has been re-
ported to suppress the LINE1 expression with piRNA pathway
during spermatogenesis until late zygotene stages, which can
compensate for defective DNA methylation and piRNA biogen-
esis in Mili mutant mice (Di Giacomo et al., 2013). Notably, the
H3K9me2 modification is globally erased shortly after the spec-
ification of PGCs at E7.5 and is absent thereafter until E12.5 (Haj-
kova et al., 2008). Thus the nuclear PRMT5-mediated repressive
H2A/H4R3me2s modification might be even more critical for the
repression of TEs in early PGCs. The H3K27me3 histone modifi-
cation was also reported to be enriched on retrotransposons at
E13.5 PGCs (Ng et al., 2013). We did not detect any obvious
difference in the H3K27me3 modification in Prmt5 mutant
PGCs at E11.5 compared to control. This suggests that thise) and the level of nuclear PRMT5 during preimplantation development (top).
he maternal-zygotic Prmt5 knockout embryos were generated followed by the
rnal-zygotic Prmt5mutant (Prmt5mat/) preimplantation embryos. The dashed
Orf1p in preimplantation embryos was determined using seven control and six
e L1Orf1p intensity of each embryo compared to the mean intensity of control
s. n, number of embryos.
ternal-zygotic Prmt5 mutant (Prmt5mat/) preimplantation embryos. The ICM
ensity of IAP-GAG in preimplantation embryos was determined in six control
nts, and the relative IAP-GAG intensity of each embryo compared to the mean
± SD of all embryos. n, number of embryos; significance was tested with the
ular Cell 56, 564–579, November 20, 2014 ª2014 Elsevier Inc. 575
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TEs, but it evidently does not compensate for the loss of H2A/
H4R3me2s at E11.5 in mutant PGCs.
There is a transient (but not sustained) developmentally pro-
grammed expression of TEs in the 2- to 4-cell-stage embryos,
which is important for the ‘‘oocyte to embryo’’ transition. Some
TEs act as alternative promoters and exons for the expression
of key host genes with significant roles in development (Peaston
et al., 2004; Fadloun et al., 2013). The transient expression of
LINE-1 and IAP at this time is unlike the aberrant expression of
LINE1 and IAP inPrmt5mutant PGCswith potentially detrimental
consequences for the germline, and thereafter for embryonic
development. While there is relatively lowH2A/H4R3me2smodi-
fication at the two-cell stage, following relocation of PRMT5 from
the cytoplasm at 4-cell stage, this modification becomes
detectable from the 8- to 16-cell stage, which coincides with
the ongoing DNA demethylation (Smith et al., 2012). The
maternal/zygotic PRMT5 plays an important role when the
DNA methylation reaches its lowest levels at the blastocyst
stage, at which point there is an upregulation of IAPs in the
mutant. However, there is no significant effect on LINE-1 expres-
sion, which might be regulated by an alternative mechanism (Fa-
dloun et al., 2013).
It is known that KAP1 and ESET can suppress TEs through the
H3K9me3 and H4K20me3 modifications (Matsui et al., 2010;
Rowe et al., 2010). While detailed analysis of these modifications
at TEs of mutant PGCs is not possible, there were no detectable
changes on the global level in H3K9me3 or H4K20me3, suggest-
ing that the loss of H2A/H4R3me2s at TEs is not compensated
by other histone modifications. On the other hand, loss of the
H2A/H4R3me2s repressive modification in Prmt5 mutant PGCs
resulted in only a few significant overall transcriptional changes.
This could be because the other repressive histone modifica-
tions might compensate for the loss of H2A/H4R3me2s (Matsui
et al., 2010; Rowe et al., 2010). Therefore, the key role of
the PRMT5 catalyzed nuclear H2A/H4R3me2s modification in
PGCs is evidently in the repression of TEs in PGCs.
The misregulation of p53 signaling genes and the apoptosis in
Prmt5 mutant PGCs is potentially a combinatorial consequence
of splicing defects and TEs-induced DNA damage response
(Belgnaoui et al., 2006; Gasior et al., 2006). The splicing defects
have been observed in other instances, such as neural progeni-
tor cells (Bezzi et al., 2013), as we also did in the Prmt5 mutant
ESCs and in postimplantation epiblast cells, which are ascribed
to the cytoplasmic PRMT5. In contrast, upregulation of TEs is a
PGC- and preimplantation embryo-specific defect in Prmt5
mutant. The expression of TEs following the loss of nuclear
PRMT5, however, is in addition to the effects of the loss of cyto-
plasmic PRMT5 in ESCs, postimplantation epiblast cells, and
neuronal progenitors (Bezzi et al., 2013). Notably, the p53
signaling-related genes including Cdkn1a (also known as p21)
are among the top differentially expressed genes in Prmt5
mutant PGCs; consistently, in Dnmt1 null fibroblasts, IAP upre-
gulation following global DNA demethylation also results in the
activation of Cdkn1a and causes p53-dependent apoptosis
(Jackson-Grusby et al., 2001). Thus, activation of TEs could
contribute to the activation of the p53-signaling pathway. Due
to subfertility of p53 mutant female mice and the small litter576 Molecular Cell 56, 564–579, November 20, 2014 ª2014 Elseviersize ofBlimp1Cre;Prmt5floxmice (4 embryos/litter, Figure S1G),
it is not possible to investigate themutant Prmt5 PGCs in the p53
null background (Hu et al., 2007).
It is known that there is a dramatic increase in DNAmethylation
after implantation of the blastocysts, as observed in the postim-
plantation epiblast cells (Borgel et al., 2010). Thus, it is possible
that DNA methylation suppresses TEs in epiblast cells, and
subsequently in most somatic tissues. Consistent with this
hypothesis,PRMT5 ispredominantly in thecytoplasmof thepost-
implantation epiblast cells, where it is likely to have other roles
such as in the regulation of alternative splicing. Indeed, deletion
of cytoplasmic PRMT5 in postimplantation epiblast cells does
not significantly affect the expression of TEs, suggesting that
DNA methylation is sufficient to suppress TEs in these cells. On
the other hand, the lack of upregulation of IAP-GAG in Prmt5
mutant hypomethylatedESCs in2i is consistentwith thepresence
of the H2A/H4R3me2smodification, which could be attributed to
Prmt7. It is likely that, as in the postimplantation epiblast, cyto-
plasmic PRMT5 in ESCs may have a role in alternative splicing.
In PGCs, PRMT5 relocates to the cytoplasm atE11.5, result-
ing in a loss of enrichment of H2A/H4R3me2s at TEs in male
PGCs at E13.5, which indicates a link between the enzyme
and the repressive mark (Figures 5F and S2A). There is initiation
of piRNAs biosynthesis after global DNA demethylation from
E8.5–E11.5 PGCs, and the expression ofMili, which is relatively
low in E10.5 PGCs, increases from E12.5 onward (Figure S7N).
PIWI proteins, MILI and MIWI2, become detectable at E12.5
and E15.5, respectively (Aravin et al., 2008; Kuramochi-Miya-
gawa et al., 2004). Interestingly, expression of Mili and Miwi2
themselves may be directly linked to DNA demethylation, which
thus couples both nuclear PRMT5 and piRNA biogenesis to
epigenetic reprogramming in PGCs (Hackett et al., 2012). Impor-
tantly, while a loss of MILI and MIWI2 results in postnatal germ
cell defects (Carmell et al., 2007), there is comprehensive and
dramatic loss of early PGCs following loss of PRMT5.
The translocation of PRMT5 to the cytoplasm after E11.5
plays yet another distinct role as it methylates murine PIWI family
proteins, which is essential for piRNA biogenesis and the
silencing of TEs (Vagin et al., 2009). Notably, the suppression
of TEs by PRMT5 through PIWI protein has also been shown
in planarians and Drosophila and is therefore evolutionarily
conserved (Kirino et al., 2010; Rouhana et al., 2012). In mice,
the mechanism of piRNA-based repression of TEs involves
DNA methylation (Aravin et al., 2008). By contrast, nuclear
PRMT5 is required in E8.5–E11.5 for the repression of TEs
through the H2A/H4R3me2s repressive chromatin modification;
amutation in Prmt5 results in loss of early PGCs in bothmale and
female embryos before the onset of meiosis (Figure 7). The role
of DNA methylation in the suppression of TEs in early PGCs is
also unlikely, since both the de novo and maintenance DNA
methylation enzymes are repressed in E8.5–E11.5 PGCs (Hack-
ett et al., 2013; Figure S5D). Furthermore, the repression of TEs
by PRMT5-mediated H2A/H4R3me2s was seen without a signif-
icant effect on DNAmethylation. In conclusion, our study reveals
a role for nuclear PRMT5 in protecting the genome by silencing
TEs at a critical time during comprehensive epigenetic reprog-
ramming and global DNA demethylation in early PGCs and pre-
implantation embryos in mice.Inc.
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Figure 7. Model of the Suppression of IAP
and LINE1 by PRMT5 in PGCs
PRMT5 has a dual function during epigenetic re-
programming of PGCs: when global DNA deme-
thylation starts (E8.5–E10.5), PRMT5 translocates
to the nucleus, and the nuclear PRMT5 catalyzes
the H2A/H4R3me2s modification to suppress IAP
and LINE1 (left). After global DNA demethylation at
E12.5, expression of Mili starts to become
detectable. PRMT5 translocates to the cytoplasm
at E11.5 to coincide with the onset of the
expression of PIWI proteins. Cytoplasmic PRMT5
is required to methylate PIWI proteins. This
methylated arginine residue recruits Tudor domain
proteins to facilitate piRNA biogenesis, which in
turn are required for the silencing of IAP and LINE1
(right).
See also Figure S7.
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Detailed experimental procedures are provided in the Supplemental
Information.
Targeted Disruption of Prmt5 Locus and Generation of Cell-Type-
Specific Prmt5 Knockout Mice
ThePrmt5 targeting vector was constructed by insertingPgk-neo flanked by frt
site and the 50 loxP site the sixth intron of Prmt5. 30 loxP site to PGK-neo
cassette was inserted into the seventh intron of Prmt5 (Figure S1). The target-
ing vector was linearized, electroporated into E14Tg2a ESCs (129/Ola).
Detailed procedure of screening and generation of mice is provided in the Sup-
plemental Information. All husbandry and experiments involving mice were
carried out according to the local ethics committee and were performed in a
facility designated by the Home Office.
Whole-Mount Immunofluorescence Staining
Embryos from timed mating were dissected and processed for immunostain-
ing as described previously (Ohinata et al., 2005). Images were acquired using
confocal microscope (Olympus, Leica) and analyzed with ImageJ software.
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